Neuropathic pain is defined as a painful condition caused by neurological lesions or
diseases. Sometimes, neurological disorders may also be associated with neuropathic pain …

Background Cladribine tablets for adult patients with highly active relapsing multiple
sclerosis (MS) have been available in Finland since 2018. Real-world data from different …

MS-taudin esiintyvyys lisääntyy maailmanlaajuisesti, ja tauti on yleistynyt Suomessakin
tasaisesti 1960-luvulta lähtien. Potilaiden eliniän pidentyminen selittää osin esiintyvyyden …

Background Alemtuzumab is an effective disease-modifying therapy (DMT) for highly active
multiple sclerosis (MS). However, safety concerns limit its use in clinical practice. Objectives …

Treatment options for multiple sclerosis (MS) are now numerous, but it is unclear which
Disease-Modifying Treatment (DMT) is the optimal choice for a given patient. Treatment …

I read the analysis of Worldwide Prevalences of Dementias, Parkinson's Disease (PD),
Multiple Sclerosis (MS) and Motor Neuron Diseases by James and Georgopoulos with great …

Finland is a relatively small genetic isolate with a genetically non-homogenous population.
Available Finnish data on neuroepidemiology of adult-onset disorders are limited, and this …

In this study, a new approach for modification of membership functions of a fuzzy inference
system (FIS) is demonstrated, in order to serve as a pattern recognition tool for classification …

Background and purpose Multiple sclerosis (MS) is associated with excess mortality. The
use of disease‐modifying treatments (DMTs) has recently been associated with survival …

Background: Infections, early life exposures and the microbiome have been associated with
the aetiology of multiple sclerosis (MS). Data on any possible roles of antibiotics is scarce …